课题基金 / 基金详情

Molecular Mechanisms Regulating Pancreatic Delta Cell Function and Dysfunction

Molecular Mechanisms Regulating Pancreatic Delta Cell Function and Dysfunction
调节胰腺 Delta 细胞功能和功能障碍的分子机制
批准号:
10443333
负责人:
David Aaron Jacobson
金额:
$44.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-04-01 至 2027-01-31

项目摘要

项目成果

David Aaron Jacobson的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 2型糖尿病患者和动物胰岛葡萄糖刺激的生长抑素(SST)分泌缺失 这种疾病的模型会导致胰升糖素和胰岛素分泌中断。这是被普遍接受的 细胞的SST分泌是对细胞内钙升高的反应,这主要是由于 内质网(ER)钙(Ca~(2+))释放。然而,控制-细胞钙内质网处理的机制 它们在T2D中是如何改变的,在很大程度上是未知的。我们实验室的数据发现,富含胰岛的两孔- 结构域K通道,Talk-1,是一种内质网局部通道,它为-细胞钙内质网的释放提供逆流 和钙离子泄漏。Talk-1介导的细胞钙电流泄漏电化学驱动力的增强 抑制葡萄糖刺激的钙内质网的释放和SST的分泌。进一步的数据显示, 葡萄糖诱导细胞的变构激活细胞的钙离子受体释放和Sst分泌。 ING受体(CASR)。最后,我们的初步数据提供了糖尿病病情减轻的第一个证据 -细胞钙内质网的储存,这有助于葡萄糖刺激的钙处理和Sst分泌的扰动 在糖尿病的情况下。基于这些令人振奋的初步数据,这项提案的总体目标是 阐明在糖尿病的发病机制中,-细胞钙内质网是如何被控制和破坏的。这个项目 将检验中心假设,即葡萄糖刺激的细胞的Sst分泌是由CaSR介导的钙离子受体放大的 释放,受Ca2ER存储的Talk-1通道约束控制。这背后的理由是 项目是了解CaSR和Talk-1如何控制-细胞钙内质网的处理和SST的分泌将暴露 T2D中恢复葡萄糖刺激的SST分泌和胰岛激素分泌的新治疗靶点。这 该项目将完成以下两个具体目标:1)确定-cell CaSR如何控制钙内质网 处理、SST分泌和胰岛激素分泌;以及2)决定Talk-1通道如何控制钙内质网 释放调节细胞的功能和功能障碍。在第一个目标下,将细胞去除的转基因小鼠 CASR以及具有细胞CaSR的shRNA敲除的人类伪胰岛将被用来评估其作用 钙感受器在分泌调节细胞钙处理和SST分泌过程中的作用。Aim1将 也确定糖尿病条件下细胞钙内质网存储的耗尽如何影响CaSR信号和SST 分泌物。在第二个目标下,功能-1\f25 Talk-1\f6上的通道-1\f25-1\f6-1\f6细胞-1\f25 Ca-1\f25 ER-1\f6的处理和功能 在细胞特异性消融Talk-1的小鼠和含有细胞的人假性胰岛中检测到 下调Talk-1或表达显性负性Talk-1通道亚单位。此外,AIM2将 确定在应激条件下Talk-1如何增加细胞钙内质网耗竭 糖尿病导致细胞功能障碍。这个项目意义重大,因为它有望照亮机械- 在T2D中改变-细胞钙离子受体处理和干扰胰岛激素分泌的NIMS。此外,这个项目将 确定使T2D患者SST分泌正常化和减少胰岛功能障碍的药物策略。
英文摘要
Project Summary Islet glucose-stimulated somatostatin (Sst) secretion is lost in patients with type-2 diabetes (T2D) and in animal models of the disease, which contributes to disrupted glucagon and insulin secretion. It is generally accepted that Sst secretion from -cells occurs in response to elevated intracellular Ca2+, which primarily results from endoplasmic reticulum (ER) Ca2+ (Ca2+ER) release. However, the mechanisms that control -cell Ca2+ER handling and how they are altered in T2D are largely unknown. Data from our lab finds that the islet-enriched two-pore- domain K+ channel, TALK-1, is an ER localized channel in that provides a countercurrent for -cell Ca2+ER release and Ca2+ER leak. TALK-1-mediated augmentation of the electrochemical driving force for -cell Ca2+ER leak con- strains Ca2+ER storage, which limits glucose-stimulated Ca2+ER release and Sst secretion. Further data show that -cell Ca2+ER release and Sst secretion are amplified by glucose-induced allosteric activation of -cell Ca2+-sens- ing receptors (CaSRs). Finally, our preliminary data provide the first evidence that diabetic conditions diminish -cell Ca2+ER storage, which contributes to perturbations in glucose-stimulated Ca2+ handling and Sst secretion under diabetic conditions. Based on these exciting preliminary data, the overall objective of this proposal is to elucidate how -cell Ca2+ER is controlled and becomes disrupted during the pathogenesis of diabetes. This project will test the central hypothesis that glucose-stimulated -cell Sst secretion is amplified by CaSR-mediated Ca2+ER release, which is controlled by TALK-1 channel constraint of Ca2+ER storage. The rationale that underlies this project is that understanding how CaSR and TALK-1 control -cell Ca2+ER handling and Sst secretion will expose novel therapeutic targets for restoring glucose-stimulated Sst secretion and islet hormone secretion in T2D. This project will be accomplished with the following two specific aims: 1) Determine how -cell CaSR controls Ca2+ER handling, Sst secretion, and islet hormone secretion; and 2) Determine how TALK-1 channel control of Ca2+ER release modulates -cell function and dysfunction. Under the first aim, transgenic mice with -cell ablation of CaSR as well as human pseudoislets with ShRNA knockdown of -cell CaSR will be utilized to assess the roles of the Ca2+-sensing receptor during secretagogue modulation of -cell Ca2+ handling and Sst secretion. Aim1 will also determine how depletion of -cell Ca2+ER stores under diabetic conditions impacts CaSR signaling and Sst secretion. Under the second aim, the function TALK-1 channels on -cell Ca2+ER handling and function will be determined in mice with -cell specific ablation of TALK-1 and in human pseudoislets containing either -cells with knockdown of TALK-1 or expressing dominant negative TALK-1 channel subunits. Furthermore, Aim2 will determine how TALK-1 augmentation of -cell Ca2+ER depletion under the stressful conditions associated with diabetes contributes to -cell dysfunction. This project is significant because it is expected to illuminate mecha- nisms that alter -cell Ca2+ER handling and disrupt islet hormone secretion in T2D. Moreover, this project will identify pharmacological strategies for normalizing Sst secretion and reducing islet dysfunction in T2D.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Secretagogue and Gi/o-GPCR signaling through the islet Na+/K+-ATPase in health and diabetes
  • 批准号:
    10717045
  • 项目类别:
  • 资助金额:
    $50.57万
  • 财政年份:
    2023
  • 负责人:
    David Aaron Jacobson
  • 依托单位:
Molecular Mechanisms Regulating Pancreatic Delta Cell Function and Dysfunction
  • 批准号:
    10597228
  • 项目类别:
  • 资助金额:
    $44.96万
  • 财政年份:
    2022
  • 负责人:
    David Aaron Jacobson
  • 依托单位:
Molecular Mechanisms Regulating Pancreatic Delta Cell Function and Dysfunction
  • 批准号:
    10899152
  • 项目类别:
  • 资助金额:
    $3.04万
  • 财政年份:
    2022
  • 负责人:
    David Aaron Jacobson
  • 依托单位:
Two-Pore-Domain Potassium Channels as Novel Targets for Modulating Islet Hormone Secretion
  • 批准号:
    10408705
  • 项目类别:
  • 资助金额:
    $39.58万
  • 财政年份:
    2019
  • 负责人:
    David Aaron Jacobson
  • 依托单位:
海外基金